Literature DB >> 17898307

Aquaporin-1 independent microvessel proliferation in a neonatal mouse model of oxygen-induced retinopathy.

Javier Ruiz-Ederra1, A S Verkman.   

Abstract

PURPOSE: Aquaporin-1 (AQP1) water channels are expressed widely in organ and tumor microvascular endothelia. Rapid microvessel proliferation occurs in growing tumors, diabetic and other retinopathies, and prenatal development. The purpose of this study was to investigate the role of AQP1 in retinal vessel proliferation.
METHODS: Comparative studies were performed on wild-type compared with AQP1 null mice using an established mouse model of oxygen-induced retinopathy. Neonatal mice were maintained in a 75% oxygen atmosphere for 5 days to suppress angiogenesis and then were returned to room air to induce vessel proliferation. AQP1 expression was also studied in extraocular microvessels and in primary endothelial cell cultures from pig retina.
RESULTS: Surprisingly, AQP1 immunoreactivity was detected in only a small percentage of newly formed retinal microvessels, whereas AQP1 was strongly expressed in all choroidal and hyaloid vessels and in various extraocular microvessels in neonatal and prenatal mice. Oxygen-induced retinal microvessel proliferation was not significantly impaired in neonatal mice lacking AQP1, as quantified in flat-mounted retinas and thin sections. However, AQP1 was expressed in endothelial cells cultured from retinal microvessels.
CONCLUSIONS: Microvessel proliferation in oxygen-induced retinopathy is AQP1-independent. Retinal endothelia have the capacity to express AQP1, though intact retinal vessels chronically suppress AQP1 expression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898307     DOI: 10.1167/iovs.07-0537

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Aquaporin-1 gene deletion reduces breast tumor growth and lung metastasis in tumor-producing MMTV-PyVT mice.

Authors:  Cristina Esteva-Font; Byung-Ju Jin; A S Verkman
Journal:  FASEB J       Date:  2013-12-12       Impact factor: 5.191

2.  Aquaporin-1 expression and angiogenesis in rabbit chronic myocardial ischemia is decreased by acetazolamide.

Authors:  Xun Ran; Haoyu Wang; Yucheng Chen; Zhi Zeng; Qin Zhou; Rong Zheng; Jiayang Sun; Bing Wang; Xiaoyan Lv; Yujia Liang; Ke Zhang; Weiqiang Liu
Journal:  Heart Vessels       Date:  2010-05-29       Impact factor: 2.037

3.  Aquaporin-1 retards renal cyst development in polycystic kidney disease by inhibition of Wnt signaling.

Authors:  Weiling Wang; Fei Li; Yi Sun; Lei Lei; Hong Zhou; Tianluo Lei; Yin Xia; A S Verkman; Baoxue Yang
Journal:  FASEB J       Date:  2015-01-08       Impact factor: 5.191

4.  Aquaporin-1-facilitated keratocyte migration in cell culture and in vivo corneal wound healing models.

Authors:  Javier Ruiz-Ederra; A S Verkman
Journal:  Exp Eye Res       Date:  2009-03-17       Impact factor: 3.467

Review 5.  Aquaporin water channels in mammals.

Authors:  Kenichi Ishibashi; Shigeki Hara; Shintaro Kondo
Journal:  Clin Exp Nephrol       Date:  2008-12-16       Impact factor: 2.801

Review 6.  Aquaporins and cell migration.

Authors:  M C Papadopoulos; S Saadoun; A S Verkman
Journal:  Pflugers Arch       Date:  2007-10-30       Impact factor: 3.657

Review 7.  Functions of aquaporins in the eye.

Authors:  A S Verkman; Javier Ruiz-Ederra; Marc H Levin
Journal:  Prog Retin Eye Res       Date:  2008-05-22       Impact factor: 21.198

Review 8.  Physiological and pathological impact of AQP1 knockout in mice.

Authors:  Ying Hua; Xinxin Ying; Yiyu Qian; Haibin Liu; Yehui Lan; Ailan Xie; Xueqiong Zhu
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

9.  Bumetanide Suppression of Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy.

Authors:  Sibel Guzel; Charles L Cai; Taimur Ahmad; Michelle Quan; Gloria B Valencia; Jacob V Aranda; Kay D Beharry
Journal:  Int J Mol Sci       Date:  2020-02-02       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.